Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Lee Pharma Limited
Location
T. Score
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

LEE PHARMA LIMITED

Active

Updated: 23 Oct 2024

The company operates as a pharmaceutical company, manufactures and exports active pharmaceutical ingredients and intermediates, chemicals, pellets and granules, and formulations.

Lee Pharma Limited, is an unlisted public company incorporated on 06 October, 1997. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 7.65 cr and the total paid-up capital is INR 1.69 cr.

Industry

Manufacturing of Pharmaceuticals

Products

control release, and multiple unit pellets; taste mask coated, and D C grade sustained release/control release/time release granules; and tablets, entric coated, D C grade plain, sustained release, time release, immediate release, uncoated, delayed release

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

10.15%

₹ GET PRO

EBITDA

14.16%

₹ GET PRO

Net Profit

22.98%

₹ GET PRO

Networth

36.12%

₹ GET PRO

Borrowings

36.46%

₹ GET PRO

Assets

19.81%

₹ GET PRO

Gross Margin

1.85

GET PRO %

Operating Margin

0.51

GET PRO %

Net Profit Margin

0.5

GET PRO %

Return on Equity

-1.78

GET PRO %

ROCE

-3.62

GET PRO %

Debt to Equity

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (9)

State	Type	Address

Locations on Map

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Equity Capital	1.5	1.5	1.5	1.5	1.5
Reserves	58.3	63.6	70.2	82.6	94.4
Borrowings +	68.6	77.6	86.3	84.7	100.3
Long term borrowings	17.6	17.4	14.7	17.3	45.0
Short term borrowings	51.0	60.2	71.6	67.3	55.3
Trade payables +	46.4	38.7	43.3	39.4	81.2
Days payable	151.0	121.0	125.0	109.0	159.0
Other liabilities +	72.7	67.4	78.7	71.0	118.7
Other non-current liabilities	8.1	9.1	10.3	7.5	13.2
Other current liabilities	18.1	19.6	25.1	24.1	24.3
Total liabilities	201.1	210.1	236.7	239.8	314.8
Fixed Assets +	57.3	67.0	76.1	90.3	132.3
Tangible assets	57.3	67.0	75.0	85.2	95.7
CWIP	-	-	0.9	5.1	36.5
Intangible assets	-	-	0.1	-	0.2
LT loans and advances	6.8	2.7	1.8	2.0	2.0
Other non-current assets	-	-	0.2	0.2	1.0
Current assets +	137.0	140.4	158.6	147.3	179.5
Inventories	49.8	54.3	64.4	69.8	96.3
Trade receivables	62.9	64.6	70.7	54.0	57.1
Cash and cash equivalents	4.9	3.2	4.1	4.7	3.8
ST loans and advances	15.1	14.7	14.4	13.3	13.3
Other current assets	4.3	3.7	5.0	5.6	9.1
Total assets	201.1	210.1	236.7	239.8	314.8

Percentage of assets	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Equity Capital	0.75	0.71	0.63	0.63	0.48
Reserves	29.01	30.3	29.66	34.45	29.98
Borrowings +	34.13	36.92	36.46	35.31	31.85
Long term borrowings	8.76	8.28	6.2	7.23	14.29
Short term borrowings	25.37	28.64	30.26	28.08	17.56
Trade payables	23.08	18.42	18.28	16.42	25.79
Other liabilities +	36.12	32.07	33.24	29.61	37.7
Other non-current liabilities	4.02	4.34	4.37	3.14	4.19
Other current liabilities	9.02	9.32	10.59	10.06	7.72
Total liabilities
Fixed Assets +	28.51	31.88	32.14	37.66	42.03
Tangible assets	28.5	31.87	31.69	35.51	30.4
CWIP	0.0	0.0	0.4	2.11	11.58
Intangible assets	0.01	0.01	0.05	0.03	0.05
LT loans and advances	3.39	1.27	0.77	0.82	0.63
Other non-current assets	0.0	0.01	0.08	0.09	0.32
Current assets +	68.1	66.84	67.01	61.43	57.02
Inventories	24.76	25.86	27.19	29.08	30.59
Trade receivables	31.25	30.75	29.87	22.5	18.13
Cash and cash equivalents	2.45	1.5	1.75	1.98	1.2
ST loans and advances	7.48	6.98	6.09	5.55	4.21
Other current assets	2.15	1.74	2.11	2.32	2.88
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Sales growth %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Precentage of total income	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Sales +	176.3	194.0	211.2	238.2	326.1
Sales growth %	None	10.02	8.87	12.79	36.9
Expenses +	172.7	189.0	204.6	227.2	309.7
Cost of goods	112.2	116.3	126.0	131.9	186.0
Employee cost	12.9	16.0	20.0	22.8	30.0
Other costs	35.3	42.3	42.7	56.6	77.9
Operating profit +	16.0	19.3	22.5	26.9	32.3
Operating margin %	9.1	10.0	10.6	11.3	9.9
Other income	2.6	3.0	1.8	0.5	2.4
Interest	7.6	9.5	10.8	10.3	9.5
Depreciation	4.7	4.8	5.1	5.6	6.3
Exceptional items	-	-	-	-	-
Profit before tax	6.0	7.8	8.3	11.4	18.7
Tax	1.7	2.5	1.7	-1.0	6.3
Profit - disc. ops	-	-	-	-	-
Net profit	4.3	5.3	6.6	12.4	12.4
Net margin %	2.4	2.7	3.1	5.2	3.8

Precentage of total income	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Sales	98.56	98.48	99.14	99.77	99.26
Expenses +	96.52	95.95	96.04	95.16	94.27
Cost of goods	62.7	59.03	59.16	55.24	56.6
Employee cost	7.22	8.14	9.39	9.54	9.12
Other costs	19.71	21.48	20.04	23.71	23.72
Operating profit	8.93	9.82	10.55	11.28	9.82
Other income	1.44	1.52	0.86	0.23	0.74
Interest	4.26	4.84	5.05	4.33	2.89
Depreciation	2.63	2.46	2.39	2.34	1.93
Exceptional items	0.0	0.0	0.0	0.0	0.0
Profit before tax	3.36	3.98	3.9	4.78	5.68
Tax	0.96	1.28	0.82	-0.42	1.91
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	2.4	2.69	3.08	5.2	3.77

Revenue from operations

Ratios

Standalone

Consolidated

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +
Total Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Debt/Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Assets/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Liquidity +
Current Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Quick Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest Coverage	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Performance
Gross Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return +
Return on Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROCE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return on Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROIC	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Efficiency +
Days Payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Inventory	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Receivable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital
Cash Conversion Cycle	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital Days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Solvency +
Total Debt/Equity	1.1	1.2	1.2	1.0	1.1
Net Debt/Equity	1.1	1.1	1.1	0.9	1.0
Total Debt/Assets	0.3	0.4	0.4	0.3	0.3
Total Assets/Equity	3.4	3.2	3.3	2.9	3.3
Liquidity +
Current Ratio	1.2	1.2	1.1	1.1	1.1
Quick Ratio	0.8	0.7	0.7	0.6	0.5
Interest Coverage	2.1	2.0	2.1	2.6	3.4
Performance
Gross Margin	36.4	40.1	40.3	44.6	43.0
Operating Margin	9.1	10.0	10.6	11.3	9.9
Net Margin	2.4	2.7	3.1	5.2	3.8
Return +
Return on Equity	7.2	8.1	9.2	14.8	12.9
Pre-tax ROCE	14.3	16.3	18.3	20.0	17.2
Return on Assets	2.1	2.5	2.8	5.2	3.9
Pre-tax ROIC	9.1	10.4	11.3	13.0	13.5
Efficiency +
Days Payable	151.0	121.0	125.0	109.0	159.0
Days Inventory	162.0	171.0	186.0	193.0	189.0
Days Receivable	130.0	122.0	122.0	83.0	64.0
Fixed Asset Turnover	3.1	2.9	2.8	2.6	2.5
Total Asset Turnover	0.9	0.9	0.9	1.0	1.0
Working Capital
Cash Conversion Cycle	141.0	172.0	183.0	167.0	94.0
Working Capital Days	44.0	41.0	32.0	25.0	21.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

SBICap Trustee Company Limited

No. of Loans: 1

Total Amount : 425.9 cr

Bajaj Finance Limited

No. of Loans: 2

Total Amount : 35.0 cr

SBI Global Factors Limited

No. of Loans: 1

Total Amount : 30.0 cr

SVC Co-Operative bank Limited

No. of Loans: 1

Total Amount : 25.0 cr

HDFC Bank Limited

No. of Loans: 1

Total Amount : 22.0 cr

Axis Bank Limited

No. of Loans: 1

Total Amount : 12.5 cr

Charge Holder	Amount	Date of creation/modification
Axis Bank Limited	12.5 cr	17 May, 2024
SVC Co-Operative bank Limited	25.0 cr	02 Jan, 2024
SBICap Trustee Company Limited	425.9 cr	15 Nov, 2023
SBI Global Factors Limited	30.0 cr	29 May, 2023
Bajaj Finance Limited	30.0 cr	19 May, 2023
Bajaj Finance Limited	5.0 cr	19 May, 2023
HDFC Bank Limited	22.0 cr	23 Mar, 2023

Charges

SBICap Trustee Company Limited

Bajaj Finance Limited

SBI Global Factors Limited

SVC Co-Operative bank Limited

Others

People

Designation	Name	DIN/PAN	Tenure
Managing Director	Venkata Reddy Alla Shareholder	00018534	28 years
Whole-time Director	Alla Ratna Kumari Shareholder	00022478	18 years
Whole-time Director	Raghumitra Alla Shareholder	00080789	19 years
Director	Anil Jain	00181960	2 years
Director	Vijaykumar Raghunandanprasad Agrawal Shareholder	01710632	18 years
Director	Santosh Babu Busani	09097558	4 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
LEE HEALTH DOMAIN INDIA PRIVATE LIMITED	Active	27.0 L	2	Telangana
LEE POWER & FUEL PRIVATE LIMITED	Strike Off	1.0 L	2	Telangana
ATCHUTAPURAM EFFLUENT TREATMENT LIMITED	Active	55.9 Cr	2	Andhra Pradesh
PHD CHAMBER OF COMMERCE AND INDUSTRY	Active	0.0	1	Delhi
EMCO LIMITED	Active	5.0 Cr	1	Maharashtra
REFEX INDUSTRIES LIMITED	Active	24.1 Cr	1	Tamil Nadu
SHERISHA TECHNOLOGIES PRIVATE LIMITED	Amalgamated	27.3 Cr	1	Tamil Nadu
AJ INCUBATION FORUM	Active	10.0 L	1	Tamil Nadu
REFEX REFRIGERANTS HARIDWAR PRIVATE LIMI TED	Strike Off	1.0 L	1	Delhi
EQC ENGINEERING PRIVATE LIMITED	Strike Off	30.0 L	1	Maharashtra
REFEX RENEWABLES & INFRASTRUCTURE LIMITED	Active	4.5 Cr	1	Tamil Nadu
ALLEGRO CREATIVE CONVERGENCE PRIVATE LIM ITED	Strike Off	0.0	1	Tamil Nadu
JITO ADMINISTRATIVE TRAINING FOUNDATION	Active	0.0	1	Maharashtra
REFEX GREEN POWER LIMITED	Active	1.0 L	1	Tamil Nadu
SUNEDISON ROOFTOP SOLAR SPV 6 PRIVATE LIMITED	Active	10.0 L	1	Tamil Nadu
SHERISHA TECHNOLOGIES PRIVATE LIMITED	Active	150.3 Cr	1	Tamil Nadu
SIL JUPITER SOLAR PRIVATE LIMITED	Active	10.0 L	1	Tamil Nadu
SIL MERCURY SOLAR PRIVATE LIMITED	Active	10.0 L	1	Tamil Nadu
SIL NEPTUNE SOLAR PRIVATE LIMITED	Active	10.0 L	1	Tamil Nadu
STPL CHEMICALS PRIVATE LIMITED	Active	1.0 L	1	Tamil Nadu
3I MEDICAL TECHNOLOGIES PRIVATE LIMITED	Active	4.5 Cr	1	Tamil Nadu
REFEX AVIATION PRIVATE LIMITED	Active	2.0 Cr	1	Tamil Nadu
REFEX AIRPORTS AND TRANSPORTATION PRIVATE LIMITED	Active	1.0 L	1	Tamil Nadu
PAVITRA MALL MANAGEMENT LLP	Strike Off	18,948.0	1	Maharashtra
LSM DEVELOPERS LLP	Active	1.0 L	1	Nadu
TRACTION INFRA LLP	Active	10.0 L	1	Nadu
REFEX CAPITAL ADVISORS LLP	Active	10.0 L	1	Nadu
SHERISHA SOLAR LLP	Active	115.8 Cr	1	Nadu
AABHUTI SPECIAL SITUATIONS ADVISORY LLP	Active	1.0 L	1	Nadu
STPL SOLUTIONS LLP	Active	10.0 L	1	Nadu
R.L.FINE CHEM PRIVATE LIMITED	Active	5.1 L	1	Karnataka
SILRES ENERGY SOLUTIONS PRIVATE LIMITED	Active	155.7 Cr	1	Tamil Nadu
SUNEDISON ENERGY SOLUTIONS PRIVATE LIMITED	Active	10.0 L	1	Tamil Nadu
RUDRA SPECIALITY CHEM PRIVATE LIMITED	Active	25.0 L	1	Maharashtra
SURVIVAL TECHNOLOGIES LIMITED	Active	17.2 Cr	1	Maharashtra
HETERO HEALTHCARE LIMITED	Active	2.0 Cr	1	Telangana

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
Lee Pharma FZE	United Arab Emirates	-	-

Registered Details

CIN

U24230TG1997PLC028095

PAN

AAACL3435F

Incorporation

1997, 27.6 years

Company Email

accounts@leepharma.com

Paid up Capital

₹ 1.7 Cr

Authorised Capital

₹ 7.7 Cr

AGM

Sep 2023

Type

Public

Non-government Company

FAQ - LEE PHARMA LIMITED

What is the incorporation date of LEE PHARMA LIMITED?

The incorporation date of LEE PHARMA LIMITED is 06 October, 1997

What is the authorized share capital of LEE PHARMA LIMITED?

The authorized share capital of LEE PHARMA LIMITED is INR ₹ 7.7 Cr.

What is the paid-up capital of LEE PHARMA LIMITED?

The paid-up capital of LEE PHARMA LIMITED is INR ₹ 1.7 Cr.

What is the registered address of LEE PHARMA LIMITED?

The registered address of LEE PHARMA LIMITED is SURVEY NO.257&258/1,DOOR NO.11-6/56,C BLOCK, OPP.IDPL FACT ORY,MOOSAPET(VILLAGE),BALAN AGAR(POST) NA HYDERABAD Hyderabad Telangana - 500037

What is the CIN number of LEE PHARMA LIMITED?

The CIN number of LEE PHARMA LIMITED is U24230TG1997PLC028095.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

LEE PHARMA LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network